These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30939531)

  • 1. Plasma Cystatin C Associates With HIV-Associated Neurocognitive Disorder but Is a Poor Diagnostic Marker in Antiretroviral Therapy-Treated Individuals.
    Kalayjian RC; Robertson KR; Albert JM; Fichtenbaum CJ; Brown TT; Taiwo BO;
    J Acquir Immune Defic Syndr; 2019 Jun; 81(2):e49-e54. PubMed ID: 30939531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher Cystatin C Levels Are Associated With Neurocognitive Impairment in Older HIV+ Adults.
    Sakoda ME; Fazeli PL; Ellis RJ; Jeste DV; Grant I; Letendre SL; Moore DJ
    J Acquir Immune Defic Syndr; 2017 Mar; 74(3):243-249. PubMed ID: 27861242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive Impairment in Well-Controlled HIV-Infected Patients: A Cross-Sectional Study.
    Portilla I; Reus S; León R; van-der Hofstadt C; Sánchez J; López N; Boix V; Merino E; Portilla J
    AIDS Res Hum Retroviruses; 2019 Jul; 35(7):634-641. PubMed ID: 30880401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of HIV Subtype and Antiretroviral Therapy on HIV-Associated Neurocognitive Disorder Stage in Rakai, Uganda.
    Sacktor N; Saylor D; Nakigozi G; Nakasujja N; Robertson K; Grabowski MK; Kisakye A; Batte J; Mayanja R; Anok A; Gray RH; Wawer MJ
    J Acquir Immune Defic Syndr; 2019 Jun; 81(2):216-223. PubMed ID: 30865184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral Blood Mitochondrial DNA Copy Number Obtained From Genome-Wide Genotype Data Is Associated With Neurocognitive Impairment in Persons With Chronic HIV Infection.
    Hulgan T; Kallianpur AR; Guo Y; Barnholtz-Sloan JS; Gittleman H; Brown TT; Ellis R; Letendre S; Heaton RK; Samuels DC;
    J Acquir Immune Defic Syndr; 2019 Apr; 80(4):e95-e102. PubMed ID: 30531306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe.
    Nyamayaro P; Gouse H; Hakim J; Robbins RN; Chibanda D
    BMC Infect Dis; 2020 May; 20(1):383. PubMed ID: 32471350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Immunodeficiency Virus-associated Neurocognitive Impairment in Diverse Resource-limited Settings.
    Robertson KR; Jiang H; Kumwenda J; Supparatpinyo K; Marra CM; Berzins B; Hakim J; Sacktor N; Campbell TB; Schouten J; Mollan K; Tripathy S; Kumarasamy N; La Rosa A; Santos B; Silva MT; Kanyama C; Firhnhaber C; Murphy R; Hall C; Marcus C; Naini L; Masih R; Hosseinipour MC; Mngqibisa R; Badal-Faesen S; Yosief S; Vecchio A; Nair A;
    Clin Infect Dis; 2019 May; 68(10):1733-1738. PubMed ID: 30219843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol consumption and neurocognitive deficits in people with well-treated HIV in Switzerland.
    Darling KEA; Locatelli I; Benghalem N; Nadin I; Calmy A; Gutbrod K; Hauser C; Brugger P; Hasse B; Kovari H; Kunze U; Stoeckle M; Fux C; Rossi S; Di Benedetto C; Früh S; Schmid P; Tarr PE; Daeppen JB; Du Pasquier R; Cavassini M;
    PLoS One; 2021; 16(3):e0246579. PubMed ID: 33651794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short Communication: Carotid Intima-Media Thickness Is Not Associated with Neurocognitive Impairment Among People Older than 50 Years With and Without HIV Infection from Thailand.
    Hiransuthikul A; Chutinet A; Sakulrak S; Samajarn J; Vongsayan P; Kijpaisalratana N; Akarathanawat W; Apornpong T; Sangarlangkarn A; Gatechompol S; Han WM; Chattranukulchai P; Kerr S; Ruxrungtham K; Avihingsanon A
    AIDS Res Hum Retroviruses; 2019; 35(11-12):1170-1173. PubMed ID: 31588776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individuals.
    Kalayjian RC; Wu K; Evans S; Clifford DB; Pallaki M; Currier JS; Smryzynski M
    J Acquir Immune Defic Syndr; 2014 Sep; 67(1):30-5. PubMed ID: 25118793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D deficiency is associated with neurocognitive impairment in HIV-infected subjects.
    Vergori A; Pinnetti C; Lorenzini P; Brita A; Libertone R; Mastrorosa I; Cicalini S; Antinori A; Ammassari A
    Infection; 2019 Dec; 47(6):929-935. PubMed ID: 31183805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen.
    Coban H; Robertson K; Smurzynski M; Krishnan S; Wu K; Bosch RJ; Collier AC; Ellis RJ
    AIDS; 2017 Jul; 31(11):1565-1571. PubMed ID: 28471765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief Report: Intracellular Cystatin B Levels Are Altered in HIV-Infected Participants With Respect to Neurocognitive Status and Antiretroviral Therapy.
    Opsteen S; Moylan D; Taiwo BO; Robertson KR; Overton ET; Cutter GR; Sabbaj S; Heath SL; Shacka JJ
    J Acquir Immune Defic Syndr; 2022 Dec; 91(5):485-489. PubMed ID: 36083516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic and Asymptomatic Neurocognitive Impairment, ART Adherence and HIV Control: A 4-Year Observational Study.
    Trunfio M; Vuaran E; Vai D; Quarta C; Di Stefano A; Imperiale D; Cinnirella G; Bonora S; Di Perri G; Letendre SL; Calcagno A
    AIDS Behav; 2024 Nov; 28(11):3643-3654. PubMed ID: 39080201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A brief and feasible paper-based method to screen for neurocognitive impairment in HIV-infected patients: the NEU screen.
    Muñoz-Moreno JA; Prats A; Pérez-Álvarez N; Fumaz CR; Garolera M; Doval E; Negredo E; Ferrer MJ; Clotet B;
    J Acquir Immune Defic Syndr; 2013 Aug; 63(5):585-92. PubMed ID: 24135776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related.
    Falasca K; Reale M; Ucciferri C; Di Nicola M; Di Martino G; D'Angelo C; Coladonato S; Vecchiet J
    AIDS Res Hum Retroviruses; 2017 Mar; 33(3):246-253. PubMed ID: 27615271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
    Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
    AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary trends in HIV-associated neurocognitive disorders in Ghana.
    Sarfo FS; Kyem G; Asibey SO; Tagge R; Ovbiagele B
    Clin Neurol Neurosurg; 2021 Nov; 210():107003. PubMed ID: 34715557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.
    Jia P; Zhao Z; Hulgan T; Bush WS; Samuels DC; Bloss CS; Heaton RK; Ellis RJ; Schork N; Marra CM; Collier AC; Clifford DB; Gelman BB; Sacktor N; Morgello S; Simpson DM; McCutchan JA; Barnholtz-Sloan JS; Franklin DR; Rosario D; Letendre SL; Grant I; Kallianpur AR;
    Am J Med Genet B Neuropsychiatr Genet; 2017 Jun; 174(4):413-426. PubMed ID: 28447399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the use of the QPC cognitive complaints questionnaire relevant for the screening strategy of HIV-Associated neurocognitive disorders?
    Zaegel-Faucher O; Laroche H; Tixier M; Morisseau V; Obry-Roguet V; Poizot-Martin I
    AIDS Care; 2021 Mar; 33(3):389-397. PubMed ID: 32279542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.